Brian Park, PharmD

Drug Information Specialist https://www.clinicaladvisor.com

Brian Park, PharmD, is a Drug Information Specialist at MPR. A graduate of the Ernest Mario School of Pharmacy, Rutgers University, Brian worked as a pharmacy manager at Stop & Shop Pharmacy for 8 years. He is a certified diabetes care pharmacist.

All articles by Brian Park, PharmD

Cardiovascular Disease Information Center

Aprocitentan Significantly Reduces BP in Patients With Resistant Hypertension

Brian Park, PharmD

May 31, 2022

The PRECISION study included adults with uncontrolled blood pressure despite at least 3 background antihypertensive medications.

Ob/Gyn Information Center

At-Home Test Helps With Birth Control Selection by Identifying Risk for Side Effects

Brian Park, PharmD

May 25, 2022

Through hormone measurements and genetic analysis, the test can identify whether an individual is at increased risk for certain birth control side effects.

Pediatrics Information Center

Pfizer-BioNTech COVID-19 Vaccine Elicits Strong Immune Response in Kids Under 5 After Third Dose

Brian Park, PharmD

May 24, 2022

The trial included 1678 children who received a third dose of the 3µg formulation at least 2 months after the second dose of a 2-dose series at a time when Omicron was the predominant variant.

ADHD Information Center

Nonstimulant ADHD Treatment Option Approved for Adults

Brian Park, PharmD

May 23, 2022

The approval of the nonstimulant agent was based on data from a phase 3 trial that assessed Qelbree in adults 18 to 65 years of age with ADHD.

Infectious Diseases Information Center

Pfizer-BioNTech COVID-19 Vaccine Booster Dose Authorized for 5 to 11 Year-Olds

Brian Park, PharmD

May 18, 2022

The Pfizer-BioNTech COVID-19 vaccine can be administered as a single booster dose to individuals 5 to 11 years of age at least 5 months after completion of the primary series.

Practice Management Information Center

Warning Letters Sent to Companies Marketing Delta-8 THC Products as Treatments

Brian Park, PharmD

May 6, 2022

The FDA has expressed serious concerns related to the potential health effects for patients who have consumed delta-8 THC products.

iSono Health's wearable 3D breast ultrasound.

Oncology Information Center

FDA Clears Automated, Wearable 3D Breast Ultrasound Device

Brian Park, PharmD

May 5, 2022

In 2 minutes, the portable ATUSA system automatically scans the entire breast volume and provides 3D visualization of the breast tissue.

Gastroenterology Information Center

Voquezna Triple, Dual Pak Approved for H. Pylori Infection Treatment

Brian Park, PharmD

May 5, 2022

The approval was based on data from a phase 3 study that compared Voquezna Triple and Dual Pak with lansoprazole plus amoxicillin and clarithromycin.

Infectious Diseases Information Center

Moderna Submits Request for Emergency Use of COVID-19 Vaccine for Young Children

Brian Park, PharmD

April 29, 2022

The KidCOVE study included children 6 months to less than 6 years of age who received either two 25mcg doses of mRNA-1273 or placebo, separated by 28 days.